Season 2 (2021-2030)

Respiratory - Antibody (1)

Modality Indication Targets Stage Company Project No. Detail
1 Development of therapeutic fully human monoclonal antibody FBPF-11X as lead compound for pulmonary fibrosis
Antibody Pulmonary fibrosis FBFP-101-T Lead FNCT Biotech HN22C0683
BACK